Ginkgo Bioworks to Go Public in a $17.5 Billion Reverse Merger With Harry Sloan's SPAC, Cathie Wood's Ark and Bill Gates' Cascade Among Investors
Tweet Send to a Friend
Biotech company Ginkgo Bioworks Inc. announced it is going public in a $17.5 billion merger with a special acquisition purpose ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
